Carbonyl Reductases and Pluripotent Hydroxysteroid Dehydrogenases of the Short-chain Dehydrogenase/reductase Superfamily

REFERENCES

• Abalain J. H., Di Stefano S., Abalain-Colloc M. L., Floch H. H. Cloning, sequencing and expression of Pseudomonas testosteroni gene encoding 3alpha-hydroxysteroid dehydrogenase. J. Steroid Biochem. Mol. Biol. 1995; 55: 233–238
   PubMed Web of Science ®Google Scholar
• Adams J. D., LaVoie E. J., Hoffmann D. On the pharmacokinetics of tobacco-specific N-nitrosamines in Fischer rats. Carcinogenesis 1985a; 6: 509–511
   PubMed Web of Science ®Google Scholar
• Adams J. D., Lavoie E. J., O'Mara-Adams K. J., Hoffmann D., Carey K. D., Marshall M. V. Pharmacokinetics of N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in laboratory animals. Cancer Lett. 1985b; 28: 195–201
   PubMed Web of Science ®Google Scholar
• Agarwal A. K., Tusie-Luna M. T., Monder C., White P. C. Expression of 11beta-hydroxysteroid dehydrogenase using recombinant vaccinia virus. Mol. Endocrinol. 1990; 4: 1827–1832
   PubMed Web of Science ®Google Scholar
• Ahmed N. K., Felsted R. L., Bachur N. R. Heterogeneity of anthracycline antibiotic carbonyl reductases in mammalian livers. Biochem. Pharmacol. 1978; 27: 2713–2719
   PubMed Web of Science ®Google Scholar
• Ahmed N. K., Felsted R. L., Bachur N. R. Comparison and characterization of mammalian xenobiotic ketone reductases. J. Pharmacol. Exp. Ther. 1979; 209: 12–19
   PubMed Web of Science ®Google Scholar
• Ahmed N. K., Felsted R. L., Bachur N. R. Daunorubicin reduction mediated by aldehyde and ketone reductases. Xenobiotica 1981; 11: 131–136
   PubMed Web of Science ®Google Scholar
• Ahrendt S. A., Chow J. T., Yang S. C., Wu L., Zhang M. J., Jen J., Sidransky D. Alcohol consumption and cigarette smoking increase the frequency of p53 mutations in non-small cell lung cancer. Cancer Res. 2000; 60: 3155–3159
   PubMed Web of Science ®Google Scholar
• Alberts P., Engblom L., Edling N., Forsgren M., Klingstrom G., Larsson C., Ronquist-Nii Y., Ohman B., Abrahmsen L. Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice. Diabetologia 2002; 45: 1528–1532
   PubMed Web of Science ®Google Scholar
• Aoki H., Okada T., Mizutani T., Numata Y., Minegishi T., Miyamoto K. Identification of two closely related genes, inducible and noninducible carbonyl reductases in the rat ovary. Biochem. Biophys. Res. Commun. 1997; 230: 518–523
   PubMed Web of Science ®Google Scholar
• Apweiler R., Attwood T. K., Bairoch A., Bateman A., Birney E., Biswas M., Bucher P., Cerutti L., Corpet F., Croning M. D., Durbin R., Falquet L., Fleischmann W., Gouzy J., Hermjakob H., Hulo N., Jonassen I., Kahn D., Kanapin A., Karavidopoulou Y., Lopez R., Marx B., Mulder N. J., Oinn T. M., Pagni M., Servant F., Sigrist C. J., Zdobnov E. M. InterPro–an integrated documentation resource for protein families, domains and functional sites. Bioinformatics 2000; 16: 1145–1150
   PubMed Web of Science ®Google Scholar
• Arda B., Aydemir S., Yamazhan T., Hassan A., Tunger A., Serter D. Comamonas testosteroni meningitis in a patient with recurrent cholesteatoma. Apmis 2003; 111: 474–476
   PubMed Web of Science ®Google Scholar
• Atalla A., Breyer-Pfaff U., Maser E. Purification and characterization of oxidoreductases-catalyzing carbonyl reduction of the tobacco-specific nitrosamine 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK) in human liver cytosol. Xenobiotica 2000; 30: 755–769
   PubMed Web of Science ®Google Scholar
• Atalla A., Maser E. Carbonyl reduction of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in cytosol of mouse liver and lung. Toxicology 1999; 139: 155–166
   PubMed Web of Science ®Google Scholar
• Auerbach G., Herrmann A., Gutlich M., Fischer M., Jacob U., Bacher A., Huber R. The 1.25 A crystal structure of sepiapterin reductase reveals its binding mode to pterins and brain neurotransmitters. Embo. J. 1997; 16: 7219–7230
   PubMed Web of Science ®Google Scholar
• Aukrust L. E., Norum K. R., Skalhegg B. A. Affinity chromatography of 3alpha-hydroxysteroid dehydrogenase from Pseudomonas testosteroni. Use of N, N-dimethylformamide to prevent hydrophobic interactions between the enzyme and the ligand. Biochim. Biophys. Acta 1976; 438: 13–22
   PubMed Web of Science ®Google Scholar
• Ax W., Soldan M., Koch L., Maser E. Development of daunorubicin resistance in tumour cells by induction of carbonyl reduction. Biochem. Pharmacol. 2000; 59: 293–300
   PubMed Web of Science ®Google Scholar
• Bachur N. R. Cytoplasmic aldo-keto reductases: A class of drug metabolizing enzymes. Science 1976; 193: 595–597
   PubMed Web of Science ®Google Scholar
• Backlund M. G., Mann J. R., Holla V. R., Buchanan F. G., Tai H. H., Musiek E. S., Milne G. L., Katkuri S., DuBois R. N. 15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer. J. Biol. Chem. 2005; 280: 3217–3223
   PubMed Web of Science ®Google Scholar
• Bairoch A., Apweiler R. The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000. Nucleic Acids Res. 2000; 28: 45–48
   PubMed Web of Science ®Google Scholar
• Baker D., Agard D. A. Kinetics versus thermodynamics in protein folding. Biochemistry 1994; 33: 7505–7509
   PubMed Web of Science ®Google Scholar
• Belai I., Darvas B., Bauer K., Tag El-Din M. H. Effects of anti-ecdysteroid azaloe analogues of metyrapone on the larval development of the fleshfly, Neobellieria bullata. Pestic. Sci. 1995; 44: 225–232
   Google Scholar
• Benach J., Atrian S., Gonzalez-Duarte R., Ladenstein R. The refined crystal structure of Drosophila lebanonensis alcohol dehydrogenase at 1.9 A resolution. J. Mol. Biol. 1998; 282: 383–399
   PubMed Web of Science ®Google Scholar
• Benach J., Atrian S., Gonzalez-Duarte R., Ladenstein R. The catalytic reaction and inhibition mechanism of Drosophila alcohol dehydrogenase: Observation of an enzyme-bound NAD-ketone adduct at 1.4 A resolution by X-ray crystallography. J. Mol. Biol. 1999; 289: 335–355
   PubMed Web of Science ®Google Scholar
• Beran M., Andersson B., Eksborg S., Ehrsson H. Comparative studies on the in vitro killing of human normal and leukemic clonogenic cells (CFUc) by daunorubicin, daunorubicinol, and daunorubicin-DNA complex. Cancer Chemother. Pharmacol. 1979; 2: 19–24
   PubMed Web of Science ®Google Scholar
• Boeijinga P. H., Galvan M., Baron B. M., Dudley M. W., Siegel B. W., Slone A. L. Characterization of the novel 5-HT3 antagonists MDL 73147EF (dolasetron mesilate) and MDL 74156 in NG108-15 neuroblastoma x glioma cells. Eur. J. Pharmacol. 1992; 219: 9–13
   PubMed Web of Science ®Google Scholar
• Bohren K. M., Bullock B., Wermuth B., Gabbay K. H. The aldo-keto reductase superfamily. cDNAs and deduced amino acid sequences of human aldehyde and aldose reductases. J. Biol. Chem. 1989; 264: 9547–9551
   PubMed Web of Science ®Google Scholar
• Bohren K. M., von Wartburg J. P., Wermuth B. Kinetics of carbonyl reductase from human brain. Biochem. J. 1987; 244: 165–171
   PubMed Web of Science ®Google Scholar
• Bohren K. M., Wermuth B., Harrison D., Ringe D., Petsko G. A., Gabbay K. H. Expression, crystallization and preliminary crystallographic analysis of human carbonyl reductase. J. Mol. Biol. 1994; 244: 659–664
   PubMed Web of Science ®Google Scholar
• Botella J. A., Ulschmid J. K., Gruenewald C., Moehle C., Kretzschmar D., Becker K., Schneuwly S. The Drosophila carbonyl reductase sniffer prevents oxidative stress-induced neurodegeneration. Curr. Biol. 2004; 14: 782–786
   PubMed Web of Science ®Google Scholar
• Breyer-Pfaff U., Martin H. J., Ernst M., Maser E. Enantioselectivity of carbonyl reduction of 4-methylnitrosamino-1-(3-pyridyl)-1-butanone by tissue fractions from human and rat and by enzymes isolated from human liver. Drug Metab. Dispos. 2004; 32: 915–922
   PubMed Web of Science ®Google Scholar
• Breyer-Pfaff U., Nill K. Stereoselective high-affinity reduction of ketonic nortriptyline metabolites and of ketotifen by aldo-keto reductases from human liver. Adv. Exp. Med. Biol. 1999; 463: 473–480
   PubMed Web of Science ®Google Scholar
• Breyer-Pfaff U., Nill K. High-affinity stereoselective reduction of the enantiomers of ketotifen and of ketonic nortriptyline metabolites by aldo-keto reductases from human liver. Biochem. Pharmacol. 2000; 59: 249–260
   PubMed Web of Science ®Google Scholar
• Breyer-Pfaff U., Nill K. Carbonyl reduction of naltrexone and dolasetron by oxidoreductases isolated from human liver cytosol. J. Pharm. Pharmacol. 2004; 56: 1601–1606
   PubMed Web of Science ®Google Scholar
• Brunmark A., Cadenas E., Segura-Aguilar J., Lind C., Ernster L. DT-diaphorase-catalyzed two-electron reduction of various p-benzoquinone- and 1,4-naphthoquinone epoxides. Free Radic. Biol. Med. 1988; 5: 133–143
   PubMed Web of Science ®Google Scholar
• Buchanan E. E., Gibbons N. E. Bergey's Manual of Determinative Bacteriology. Williams and Wilkins, Baltimore, MD 1974
   Google Scholar
• Buffinton G. D., Ollinger K., Brunmark A., Cadena E. DT-diaphorase-catalysed reduction of 1,4-naphthoquinone derivatives and glutathionyl-quinone conjugates. Effect of substituents on autoxidation rates. Biochem. J. 1989; 257: 561–571
   PubMed Web of Science ®Google Scholar
• Cagen L. M., Zusman R. M., Pisano J. J. Formation of 1a, 1b dihomoprostaglandin E2 by rabbit renal intersititial cell cultures. Prostaglandins 1979; 18: 617–621
   PubMed Web of Science ®Google Scholar
• Caldwell J. The biochemical pharmacology of fenofibrate. Cardiology. 1989; 76(Suppl 1)33–41; discussion 41–44
   PubMed Web of Science ®Google Scholar
• Carmella S. G., Akerkar S. A., Richie J. P., Jr., Hecht S. S. Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine. Cancer Epidemiol. Biomarkers Prev. 1995; 4: 635–642
   PubMed Web of Science ®Google Scholar
• Carmella S. G., Borukhova A., Akerkar S. A., Hecht S. S. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen. Cancer Epidemiol. Biomarkers Prev. 1997; 6: 113–120
   PubMed Web of Science ®Google Scholar
• Chang D. G., Tai H. H. Prostaglandin 9-ketoreductase/type II 15-hydroxyprostaglandin dehydrogenase is not a prostaglandin specific enzyme. Biochem. Biophys. Res. Commun. 1981; 101: 898–904
   PubMed Web of Science ®Google Scholar
• Chen S., Wu K., Knox R. Structure-function studies of DT-diaphorase (NQO1) and NRH: Quinone oxidoreductase (NQO2). Free Radic. Biol. Med. 2000; 29: 276–284
   PubMed Web of Science ®Google Scholar
• Coenye T., Goris J., Spilker T., Vandamme P., LiPuma J. J. Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of Inquilinus limosus gen. nov., sp. nov. J. Clin. Microbiol. 2002; 40: 2062–2069
   PubMed Web of Science ®Google Scholar
• Cooper G. R., Staples E. D., Iczkowski K. A., Clancy C. J. Comamonas (Pseudomonas) testosteroni endocarditis. Cardiovasc. Pathol. 2005; 14: 145–149
   PubMed Web of Science ®Google Scholar
• Cromlish J. A., Yoshimoto C. K., Flynn T. G. Purification and characterization of four NADPH-dependent aldehyde reductases from pig brain. J. Neurochem. 1985; 44: 1477–1484
   PubMed Web of Science ®Google Scholar
• Darvas B., Belai I., Fonagy A., Kulcsar P., Tag El-Din M. H. Lethal disturbances in larval development of Neobellieria bullata caused by metyrapone derivates. Pestic. Sci. 1991; 32: 133–139
   Google Scholar
• Dawson T. M., Dawson V. L. Molecular pathways of neurodegeneration in Parkinson's disease. Science 2003; 302: 819–822
   PubMed Web of Science ®Google Scholar
• Dayton H. E., Inturrisi C. E. The urinary excretion profiles of naltrexone in man, monkey, rabbit, and rat. Drug Metab. Dispos. 1976; 4: 474–478
   PubMed Web of Science ®Google Scholar
• Dessypris E. N., Brenner D. E., Hande K. R. Toxicity of doxorubicin metabolites to human marrow erythroid and myeloid progenitors in vitro. Cancer Treat. Rep. 1986; 70: 487–490
   PubMedGoogle Scholar
• Diederich S., Hanke B., Burkhardt P., Muller M., Schoneshofer M., Bahr V., Oelkers W. Metabolism of synthetic corticosteroids by 11beta-hydroxysteroid-dehydrogenases in man. Steroids 1998; 63: 271–277
   PubMed Web of Science ®Google Scholar
• Diederich S., Hanke B., Oelkers W., Bahr V. Metabolism of dexamethasone in the human kidney: Nicotinamide adenine dinucleotide-dependent 11beta-reduction. J. Clin. Endocrinol. Metab. 1997; 82: 1598–1602
   PubMed Web of Science ®Google Scholar
• Doorn J. A., Maser E., Blum A., Claffey D. J., Petersen D. R. Human carbonyl reductase catalyzes reduction of 4-oxonon-2-enal. Biochemistry 2004; 43: 13106–13114
   PubMed Web of Science ®Google Scholar
• Duax W. L., Ghosh D., Pletnev V. Steroid dehydrogenase structures, mechanism of action, and disease. Vitam. Horm. 2000; 58: 121–148
   PubMed Web of Science ®Google Scholar
• Ellis E. M. Microbial aldo-keto reductases. FEMS Microbiol. Lett. 2002; 216: 123–131
   PubMed Web of Science ®Google Scholar
• Ellis E. M., Hayes J. D. Substrate specificity of an aflatoxin-metabolizing aldehyde reductase. Biochem. J. 1995; 312(Pt 2)535–541
   PubMed Web of Science ®Google Scholar
• Ensor C. M., Tai H. H. Site-directed mutagenesis of the conserved tyrosine 151 of human placental NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase yields a catalytically inactive enzyme. Biochem. Biophys. Res. Commun. 1991; 176: 840–845
   PubMed Web of Science ®Google Scholar
• Espey L. L., Yoshioka S., Russell D., Ujioka T., Vladu B., Skelsey M., Fujii S., Okamura H., Richards J. S. Characterization of ovarian carbonyl reductase gene expression during ovulation in the gonadotropin-primed immature rat. Biol. Reprod. 2000; 62: 390–397
   PubMed Web of Science ®Google Scholar
• Esterbauer H., Cheeseman K. H., Dianzani M. U., Poli G., Slater T. F. Separation and characterization of the aldehydic products of lipid peroxidation stimulated by ADP-Fe2+ in rat liver microsomes. Biochem. J. 1982; 208: 129–140
   PubMed Web of Science ®Google Scholar
• Faber K. Biotransformations in Organic Chemistry. 2nd. Springer-Verlag, Berlin 1998
   Google Scholar
• Felsted R. L., Bachur N. R. Mammalian carbonyl reductases. Drug Metab. Rev. 1980; 11: 1–60
   PubMed Web of Science ®Google Scholar
• Felsted R. L., Bachur N. R. Human liver daunorubicin reductases. Prog. Clin. Biol. Res. 1982; 114: 291–305
   PubMedGoogle Scholar
• Floch H. H., Abalain J. H., Di Stefano S., Carre J. L., Abalain-Colloc M. L. Cloning of genes coding for 3-alpha-hydroxysteroid dehydrogenase and for (3–17)-beta-hydroxysteroid dehydrogenase from Pseudomonas testosteroni. C. R. Seances Soc. Biol. Fil. 1995; 189: 705–712
   PubMedGoogle Scholar
• Flynn T. G., Green N. C. The aldo-keto reductases: An overview. Adv. Exp. Med. Biol. 1993; 328: 251–257
   PubMedGoogle Scholar
• Ford G., Ellis E. M. Three aldo-keto reductases of the yeast Saccharomyces cerevisiae. Chem. Biol. Interact. 2001; 130–132: 685–698
   PubMed Web of Science ®Google Scholar
• Ford G., Ellis E. M. Characterization of Ypr1p from Saccharomyces cerevisiae as a 2-methylbutyraldehyde reductase. Yeast 2002; 19: 1087–1096
   PubMed Web of Science ®Google Scholar
• Forrest G. L., Akman S., Krutzik S., Paxton R. J., Sparkes R. S., Doroshow J., Felsted R. L., Glover C. J., Mohandas T., Bachur N. R. Induction of a human carbonyl reductase gene located on chromosome 21. Biochim. Biophys. Acta 1990; 1048: 149–155
   PubMed Web of Science ®Google Scholar
• Forrest G. L., Gonzalez B. Carbonyl reductase. Chem. Biol. Interact. 2000; 129: 21–40
   PubMed Web of Science ®Google Scholar
• Fujii J., Iuchi Y., Okada F. Fundamental roles of reactive oxygen species and protective mechanisms in the female reproductive system. Reprod. Biol. Endocrinol. 2005; 3: 43
   PubMed Web of Science ®Google Scholar
• Gersl V., Mazurova Y., Bajgar J., Melka M., Hrdina R., Palicka V. Lack of cardiotoxicity of a new antineoplastic agent, a synthetic derivative of indenoisochinoline: Comparison with daunorubicin in rabbits. Arch. Toxicol. 1996; 70: 645–651
   PubMed Web of Science ®Google Scholar
• Gessner T., Vaughan L. A., Beehler B. C., Bartels C. J., Baker R. M. Elevated pentose cycle and glucuronyltransferase in daunorubicin-resistant P388 cells. Cancer Res. 1990; 50: 3921–3927
   PubMed Web of Science ®Google Scholar
• Ghosh D., Erman M., Pangborn W., Duax W. L., Baker M. E. Inhibition of Streptomyces hydrogenans 3alpha,20beta-hydroxysteroid dehydrogenase by licorice-derived compounds and crystallization of an enzyme-cofactor-inhibitor complex. J. Steroid. Biochem. Mol. Biol. 1992; 42: 849–853
   PubMed Web of Science ®Google Scholar
• Ghosh D., Erman M., Pangborn W., Duax W. L., Nakajin S., Ohno S., Shinoda M. Crystallization and preliminary X-ray diffraction studies of a mammalian steroid dehydrogenase. J. Steroid. Biochem. Mol. Biol. 1993; 46: 103–104
   PubMed Web of Science ®Google Scholar
• Ghosh D., Erman M., Wawrzak Z., Duax W. L., Pangborn W. Mechanism of inhibition of 3 alpha, 20 beta-hydroxysteroid dehydrogenase by a licorice-derived steroidal inhibitor. Structure 1994a; 2: 973–980
   PubMed Web of Science ®Google Scholar
• Ghosh D., Pletnev V. Z., Zhu D. W., Wawrzak Z., Duax W. L., Pangborn W., Labrie F., Lin S. X. Structure of human estrogenic 17beta-hydroxysteroid dehydrogenase at 2.20 A resolution. Structure 1995; 3: 503–513
   PubMed Web of Science ®Google Scholar
• Ghosh D., Sawicki M., Pletnev V., Erman M., Ohno S., Nakajin S., Duax W. L. Porcine carbonyl reductase. Structural basis for a functional monomer in short chain dehydrogenases/reductases. J. Biol. Chem. 2001; 276: 18457–18463
   PubMed Web of Science ®Google Scholar
• Ghosh D., Wawrzak Z., Weeks C. M., Duax W. L., Erman M. The refined three-dimensional structure of 3alpha,20beta-hydroxysteroid dehydrogenase and possible roles of the residues conserved in short-chain dehydrogenases. Structure 1994b; 2: 629–640
   PubMed Web of Science ®Google Scholar
• Ghosh D., Weeks C. M., Grochulski P., Duax W. L., Erman M., Rimsay R. L., Orr J. C. Three-dimensional structure of holo 3alpha,20beta-hydroxysteroid dehydrogenase: A member of a short-chain dehydrogenase family. Proc. Natl. Acad. Sci. USA 1991; 88: 10064–10068
   PubMed Web of Science ®Google Scholar
• Gonzalez B., Sapra A., Rivera H., Kapla n W. D., Yam B., Forrest G. L. Cloning and expression of the cDNA encoding rabbit liver carbonyl reductase. Gene. 1995; 154: 297–298
   PubMed Web of Science ®Google Scholar
• Grimm C., Maser E., Möbus E., Klebe G., Reuter K., Ficner R. The crystal structure of 3alpha -hydroxysteroid dehydrogenase/carbonyl reductase from Comamonas testosteroni shows a novel oligomerization pattern within the short chain dehydrogenase/reductase family. J. Biol. Chem. 2000; 275: 41333–41339
   PubMed Web of Science ®Google Scholar
• Guan G., Tanaka M., Todo T., Young G., Yoshikuni M., Nagahama Y. Cloning and expression of two carbonyl reductase-like 20beta-hydroxysteroid dehydrogenase cDNAs in ovarian follicles of rainbow trout (Oncorhynchus mykiss). Biochem. Biophys. Res. Commun. 1999; 255: 123–128
   PubMed Web of Science ®Google Scholar
• Habrych M., Rodriguez S., Stewart J. D. Purification and identification of an Escherichia coli beta-keto ester reductase as 2,5-diketo-D-gluconate reductase YqhE. Biotechnol. Prog. 2002; 18: 257–261
   PubMed Web of Science ®Google Scholar
• Hara A., Hasebe K., Hayashibara M., Matsuura K., Nakayama T., Sawada H. Dihydrodiol dehydrogenases in guinea pig liver. Biochem. Pharmacol. 1986a; 35: 4005–4012
   PubMed Web of Science ®Google Scholar
• Hara A., Nakayama T., Deyashiki Y., Kariya K., Sawada H. Carbonyl reductase of dog liver: Purification, properties, and kinetic mechanism. Arch. Biochem. Biophys. 1986b; 244: 238–247
   PubMed Web of Science ®Google Scholar
• Hara A., Oritani H., Deyashiki Y., Nakayama T., Sawada H. Activation of carbonyl reductase from pig lung by fatty acids. Arch. Biochem. Biophys. 1992; 292: 548–554
   PubMed Web of Science ®Google Scholar
• Hara A., Usui S., Hayashibara M., Horiuchi T., Nakayama T., Sawada H. Microsomal carbonyl reductase in rat liver. Sex difference, hormonal regulation, and characterization. Prog. Clin. Biol. Res. 1987; 232: 401–414
   PubMedGoogle Scholar
• Hara A., Yamamoto H., Deyashiki Y., Nakayama T., Oritani H., Sawada H. Aldehyde dismutation catalyzed by pulmonary carbonyl reductase: Kinetic studies of chloral hydrate metabolism to trichloroacetic acid and trichloroethanol. Biochim. Biophys. Acta. 1991; 1075: 61–67
   PubMed Web of Science ®Google Scholar
• Hartl F. U., Pfanner N., Nicholson D. W., Neupert W. Mitochondrial protein import. Biochim. Biophys. Acta. 1989; 988: 1–45
   PubMed Web of Science ®Google Scholar
• Hayashi H., Fujii Y., Watanabe K., Urade Y., Hayaishi O. Enzymatic conversion of prostaglandin H2 to prostaglandin F2 alpha by aldehyde reductase from human liver. Prog. Clin. Biol. Res. 1989; 290: 365–379
   PubMedGoogle Scholar
• Hecht S. S. Metabolic activation and detoxification of tobacco-specific nitrosamines–a model for cancer prevention strategies. Drug Metab. Rev. 1994; 26: 373–390
   PubMed Web of Science ®Google Scholar
• Hecht S. S. Recent studies on mechanisms of bioactivation and detoxification of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific lung carcinogen. Crit. Rev. Toxicol. 1996; 26: 163–181
   PubMed Web of Science ®Google Scholar
• Hecht S. S. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem. Res. Toxicol. 1998; 11: 559–603
   PubMed Web of Science ®Google Scholar
• Hecht S. S., Carmella S. G., Murphy S. E., Akerkar S., Brunnemann K. D., Hoffmann D. A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke. N. Engl. J. Med. 1993; 329: 1543–1546
   PubMed Web of Science ®Google Scholar
• Higaki Y., Usami N., Shintani S., Ishikura S., El-Kabbani O., Hara A. Selective and potent inhibitors of human 20alpha-hydroxysteroid dehydrogenase (AKR1C1) that metabolizes neurosteroids derived from progesterone. Chem. Biol. Interact. 2003; 143–144: 503–513
   PubMed Web of Science ®Google Scholar
• Higuchi T., Imamura Y., Otagiri M. Kinetic studies on the reduction of acetohexamide catalyzed by carbonyl reductase from rabbit kidney. Biochim. Biophys. Acta 1993; 1158: 23–28
   PubMed Web of Science ®Google Scholar
• Hoffmann D., Lavoie E. J., Hecht S. S. Nicotine: A precursor for carcinogens. Cancer Lett. 1985; 26: 67–75
   PubMed Web of Science ®Google Scholar
• Hoffmann F., Sotriffer C., Evers A., Xiong G., Maser E. Understanding oligomerization in 3alpha -hydroxysteroid dehydrogenase/carbonyl reductase from Comamonas testosteroni: An in silico approach and evidence for an active protein. J. Biotechnol. 2007, in press
   Web of Science ®Google Scholar
• Iino T., Tabata M., Takikawa S., Sawada H., Shintaku H., Ishikura S., Hara A. Tetrahydrobiopterin is synthesized from 6-pyruvoyl-tetrahydropterin by the human aldo-keto reductase AKR1 family members. Arch Biochem Biophys 2003; 416: 180–187
   PubMed Web of Science ®Google Scholar
• Iino T., Takikawa S. I., Yamamoto T., Sawada H. The enzyme that synthesizes tetrahydrobiopterin from 6-pyruvoyl-tetrahydropterin in the lemon mutant silkworm consists of two carbonyl reductases. Arch. Biochem. Biophys. 2000; 373: 442–446
   PubMed Web of Science ®Google Scholar
• Ikeda M., Hattori H., Ohmori S. Properties of NADPH-dependent carbonyl reductases in rat liver cytosol. Biochem. Pharmacol. 1984; 33: 3957–3961
   PubMed Web of Science ®Google Scholar
• Imamura Y., Higuchi T., Nozaki Y., Sugino E., Hibino S., Otagiri M. Purification and properties of carbonyl reductase from rabbit kidney. Arch. Biochem. Biophys. 1993; 300: 570–576
   PubMed Web of Science ®Google Scholar
• Imamura Y., Migita T., Anraku M., Otagiri M. Inhibition of rabbit heart carbonyl reductase by fatty acids. Biol. Pharm. Bull. 1999a; 22: 731–733
   PubMed Web of Science ®Google Scholar
• Imamura Y., Migita T., Otagiri M., Choshi T. , Hibino S. Purification and catalytic properties of a tetrameric carbonyl reductase from rabbit heart. J. Biochem. (Tokyo) 1999b; 125: 41–47
   PubMed Web of Science ®Google Scholar
• Inazu N., Fujii T. Pre- and post-ovulatory changes in carbonyl reductase in ovarian follicles and corpora lutea in rats. Res. Commun. Mol. Pathol. Pharmacol. 1997; 98: 325–334
   PubMed Web of Science ®Google Scholar
• Inazu N., Inaba N., Satoh T., Fujii T. Human chorionic gonadotropin causes an estrogen-mediated induction of rat ovarian carbonyl reductase. Life Sci. 1992a; 51: 817–822
   PubMed Web of Science ®Google Scholar
• Inazu N., Ruepp B., Wirth H., Wermuth B. Carbonyl reductase from human testis: Purification and comparison with carbonyl reductase from human brain and rat testis. Biochim. Biophys. Acta 1992b; 1116: 50–56
   PubMed Web of Science ®Google Scholar
• Inazu N., Satoh T. Activation by human chorionic gonadotropin of ovarian carbonyl reductase in mature rats exposed in vivo to estrogens. Biochem. Pharmacol. 1994; 47: 1489–1496
   PubMed Web of Science ®Google Scholar
• Iwata N., Inazu N., Satoh T. The purification and properties of NADPH-dependent carbonyl reductases from rat ovary. J. Biochem. (Tokyo) 1989; 105: 556–564
   PubMed Web of Science ®Google Scholar
• Iwata N., Inazu N., Satoh T. Immunological and enzymological localization of carbonyl reductase in ovary and liver of various species. J. Biochem. (Tokyo) 1990a; 107: 209–212
   PubMed Web of Science ®Google Scholar
• Iwata N., Inazu N., Takeo S., Satoh T. Carbonyl reductases from rat testis and vas deferens. Purification, properties and localization. Eur. J. Biochem. 1990b; 193: 75–81
   PubMedGoogle Scholar
• Jarabak J., Luncsford A., Berkowitz D. Substrate specificity of three prostaglandin dehydrogenases. Prostaglandins 1983; 26: 849–868
   PubMed Web of Science ®Google Scholar
• Jez J. M., Bennett M. J., Schlegel B. P., Lewis M., Penning T. M. Comparative anatomy of the aldo-keto reductase superfamily. Biochem. J. 1997a; 326(Pt 3)625–636
   PubMed Web of Science ®Google Scholar
• Jez J. M., Flynn T. G., Penning T. M. A new nomenclature for the aldo-keto reductase superfamily. Biochem. Pharmacol. 1997b; 54: 639–647
   PubMed Web of Science ®Google Scholar
• Joo M., Kang Y. K., Lee H. K., Lee H. S., Yum H. K., Bang S. W., Cho H. J. Intrapulmonary and gastric teratoma: Report of two cases. J. Korean Med. Sci. 1999; 14: 330–334
   PubMed Web of Science ®Google Scholar
• Jornvall H., Hoog J. O., Persson B. SDR and MDR: Completed genome sequences show these protein families to be large, of old origin, and of complex nature. FEBS Lett. 1999; 445: 261–264
   PubMed Web of Science ®Google Scholar
• Jornvall H., Persson M., Jeffery J. Alcohol and polyol dehydrogenases are both divided into two protein types, and structural properties cross-relate the different enzyme activities within each type. Proc. Natl. Acad. Sci. USA 1981; 78: 4226–4230
   PubMed Web of Science ®Google Scholar
• Jornvall H., Persson B., Krook M., Atrian S., Gonzalez-Duarte R., Jeffery J., Ghosh D. Short-chain dehydrogenases/reductases (SDR). Biochemistry 1995; 34: 6003–6013
   PubMed Web of Science ®Google Scholar
• Kallberg Y., Oppermann U., Jörnvall H., Persson B. Short-chain dehydrogenase/reductase (SDR) relationships: A large family with eight clusters common to human, animal, and plant genomes. Protein Sci. 2002; 11: 636–641
   PubMed Web of Science ®Google Scholar
• Kallberg Y., Persson B. KIND-a non-redundant protein database. Bioinformatics 1999; 15: 260–261
   PubMed Web of Science ®Google Scholar
• Karplus K., Barrett C., Hughey R. Hidden Markov models for detecting remote protein homologies. Bioinformatics 1998; 14: 846–856
   PubMed Web of Science ®Google Scholar
• Karplus K., Karchin R., Shackelford G., Hughey R. Calibrating E-values for hidden Markov models using reverse-sequence null models. Bioinformatics 2005; 21: 4107–4115
   PubMed Web of Science ®Google Scholar
• Kita K., Fukura T., Nakase K. I., Okamoto K., Yanase H., Kataoka M., Shimizu S. Cloning, overexpression, and mutagenesis of the Sporobolomyces salmonicolor AKU4429 gene encoding a new aldehyde reductase, which catalyzes the stereoselective reduction of ethyl 4-chloro-3-oxobutanoate to ethyl (S)-4-chloro-3-hydroxybutanoate. Appl. Environ. Microbiol. 1999; 65: 5207–5211
   PubMed Web of Science ®Google Scholar
• Klein J., Thomas H., Post K., Worner W., Oesch F. Dihydrodiol dehydrogenase activities of rabbit liver are associated with hydroxysteroid dehydrogenases and aldo-keto reductases. Eur. J. Biochem. 1992; 205: 1155–1162
   PubMedGoogle Scholar
• Kotelevtsev Y., Holmes M. C., Burchell A., Houston P. M., Schmoll D., Jamieson P., Best R., Brown R., Edwards C. R., Seckl J. R., Mullins J. J. 11Beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc. Natl. Acad. Sci. USA 1997; 94: 14924–14929
   PubMed Web of Science ®Google Scholar
• Krook M., Ghosh D., Duax W., Jornvall H. Three-dimensional model of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase and relationships to the NADP(+)-dependent enzyme (carbonyl reductase). FEBS Lett. 1993a; 322: 139–142
   PubMed Web of Science ®Google Scholar
• Krook M., Ghosh D., Stromberg R., Carlquist M., Jornvall H. Carboxyethyllysine in a protein: Native carbonyl reductase/NADP(+)-dependent prostaglandin dehydrogenase. Proc. Natl. Acad. Sci. USA 1993b; 90: 502–506
   PubMed Web of Science ®Google Scholar
• Krozowski Z. 11 Beta-hydroxysteroid dehydrogenase and the short-chain alcohol dehydrogenase (SCAD) superfamily. Mol. Cell. Endocrinol. 1992; 84: C25–31
   PubMed Web of Science ®Google Scholar
• Labrie F., Luu-The V., Lin S. X., Labrie C., Simard J., Breton R., Belanger A. The key role of 17beta-hydroxysteroid dehydrogenases in sex steroid biology. Steroids 1997; 62: 148–158
   PubMed Web of Science ®Google Scholar
• Lakhman S. S., Ghosh D., Blanco J. G. Functional significance of a natural allelic variant of human carbonyl reductase 3 (CBR3). Drug Metab. Dispos. 2005; 33: 254–257
   PubMed Web of Science ®Google Scholar
• Lee S. C., Levine L. Prostaglandin metabolism. I. Cytoplasmic reduced nicotinamide adenine dinucleotide phosphate-dependent and microsomal reduced nicotinamide adenine dinucleotide-dependent prostaglandin E 9-ketoreductase activities in monkey and pigeon tissues. J. Biol. Chem. 1974a; 249: 1369–1375
   PubMed Web of Science ®Google Scholar
• Lee S. C., Levine L. Purification and properties of chicken heart prostaglandin delta13-reductase. Biochem. Biophys. Res. Commun. 1974b; 61: 14–21
   PubMed Web of Science ®Google Scholar
• Li K. X., Obeyesekere V. R., Krozowski Z. S., Ferrari P. Oxoreductase and dehydrogenase activities of the human and rat 11beta-hydroxysteroid dehydrogenase type 2 enzyme. Endocrinology 1997; 138: 2948–2952
   PubMed Web of Science ®Google Scholar
• Lin D., Lee H. G., Liu Q., Perry G., Smith M. A., Sayre L. M. 4-Oxo-2-nonenal is both more neurotoxic and more protein reactive than 4-hydroxy-2-nonenal. Chem. Res. Toxicol. 2005; 18: 1219–1231
   PubMed Web of Science ®Google Scholar
• Lind C., Cadenas E., Hochstein P., Ernster L. DT-Diaphorase: Purification, properties, and function. Methods Enzymol. 1990; 186: 287–301
   PubMed Web of Science ®Google Scholar
• Lind C., Hochstein P., Ernster L. DT-Diaphorase as a quinone reductase: A cellular control device against semiquinone and superoxide radical formation. Arch. Biochem. Biophys. 1982; 216: 178–185
   PubMed Web of Science ®Google Scholar
• Maser E. The purification and properties of a novel carbonyl reducing enzyme from mouse liver microsomes. Adv. Exp. Med. Biol. 1993; 328: 339–350
   PubMedGoogle Scholar
• Maser E. Xenobiotic carbonyl reduction and physiological steroid oxidoreduction. The pluripotency of several hydroxysteroid dehydrogenases. Biochem. Pharmacol. 1995; 49: 421–440
   PubMed Web of Science ®Google Scholar
• Maser E. Stress, hormonal changes, alcohol, food constituents and drugs: Factors that advance the incidence of tobacco smoke-related cancer?. Trends Pharmacol. Sci. 1997; 18: 270–275
   PubMed Web of Science ®Google Scholar
• Maser E. 11Beta-hydroxysteroid dehydrogenase responsible for carbonyl reduction of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)- 1-butanone in mouse lung microsomes. Cancer Res. 1998; 58: 2996–3003
   PubMed Web of Science ®Google Scholar
• Maser E. Significance of reductases in the detoxification of the tobacco-specific carcinogen NNK. Trends Pharmacol. Sci. 2004; 25: 235–237
   PubMed Web of Science ®Google Scholar
• Maser E. Neuroprotective role for carbonyl reductase?. Biochem. Biophys. Res. Commun. 2006; 340: 1019–1022
   PubMed Web of Science ®Google Scholar
• Maser E., Bannenberg G. 11Beta-hydroxysteroid dehydrogenase mediates reductive metabolism of xenobiotic carbonyl compounds. Biochem. Pharmacol. 1994a; 47: 1805–1812
   PubMed Web of Science ®Google Scholar
• Maser E., Bannenberg G. The purification of 11beta-hydroxysteroid dehydrogenase from mouse liver microsomes. J. Steroid. Biochem. Mol. Biol. 1994b; 48: 257–263
   PubMed Web of Science ®Google Scholar
• Maser E., Friebertshauser J., Mangoura S. A. Ontogenic pattern of carbonyl reductase activity of 11beta-hydroxysteroid dehydrogenase in mouse liver and kidney. Xenobiotica 1994; 24: 109–117
   PubMed Web of Science ®Google Scholar
• Maser E., Friebertshauser J., Volker B. Purification, characterization and NNK carbonyl reductase activities of 11beta-hydroxysteroid dehydrogenase type 1 from human liver: Enzyme cooperativity and significance in the detoxification of a tobacco-derived carcinogen. Chem. Biol. Interact. 2003; 143–144: 435–448
   PubMed Web of Science ®Google Scholar
• Maser E., Hoffmann J. G., Friebertshauser J., Netter K. J. High carbonyl reductase activity in adrenal gland and ovary emphasizes its role in carbonyl compound detoxication. Toxicology 1992; 74: 45–56
   PubMed Web of Science ®Google Scholar
• Maser E., Oppermann U. C. Molecular cloning and sequencing of mouse hepatic 11beta-hydroxysteroid dehydrogenase/carbonyl reductase. A member of the short chain dehydrogenase superfamily. Adv. Exp. Med. Biol. 1995; 372: 211–221
   PubMedGoogle Scholar
• Maser E., Oppermann U. C. Role of type-1 11beta-hydroxysteroid dehydrogenase in detoxification processes. Eur. J. Biochem. 1997; 249: 365–369
   PubMedGoogle Scholar
• Maser E., Richter E., Friebertshauser J. The identification of 11beta-hydroxysteroid dehydrogenase as carbonyl reductase of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Eur. J. Biochem. 1996; 238: 484–489
   PubMedGoogle Scholar
• Maser E., Volker B., Friebertshauser J. 11Beta-hydroxysteroid dehydrogenase type 1 from human liver: dimerization and enzyme cooperativity support its postulated role as glucocorticoid reductase. Biochemistry 2002; 41: 2459–2465
   PubMed Web of Science ®Google Scholar
• Maser E., Wsol V., Martin H. J. 11Beta-hydroxysteroid dehydrogenase type 1: purification from human liver and characterization as carbonyl reductase of xenobiotics. Mol. Cell. Endocrinol. 2006; 248: 34–37
   PubMed Web of Science ®Google Scholar
• Masuzaki H., Paterson J., Shinyama H., Morton N. M., Mullins J. J., Seckl J. R., Flier J. S. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001; 294: 2166–2170
   PubMed Web of Science ®Google Scholar
• Matsuda T., Harada T., Nakajima N., Itoh T., Nakamura K. Two classes of enzymes of opposite stereochemistry in an organism: One for fluorinated and another for nonfluorinated substrates. J. Org. Chem. 2000; 65: 157–163
   PubMed Web of Science ®Google Scholar
• Matsunaga T., Shintani S., Hara A. Multiplicity of mammalian reductases for xenobiotic carbonyl compounds. Drug Metab. Pharmacokinet. 2006; 21: 1–18
   PubMed Web of Science ®Google Scholar
• Matsuura K., Bunai Y., Ohya I., Hara A., Nakanishi M., Sawada H. Ultrastructural localization of carbonyl reductase in mouse lung. Histochem. J. 1994; 26: 311–316
   PubMedGoogle Scholar
• Matsuura K., Hara A., Sawada H., Bunai Y., Ohya I. Localization of pulmonary carbonyl reductase in guinea pig and mouse: Enzyme histochemical and immunohistochemical studies. J. Histochem. Cytochem. 1990; 38: 217–223
   PubMed Web of Science ®Google Scholar
• Matsuura K., Naganeo F., Hara A., Nakayama T., Nakagawa M., Sawada H. Pulmonary carbonyl reductase: Metabolism of carbonyl products in lipid peroxidation. Prog. Clin. Biol. Res. 1989; 290: 335–349
   PubMedGoogle Scholar
• Matsuura K., Nakayama T., Nakagawa M., Hara A., Sawada H. Kinetic mechanism of pulmonary carbonyl reductase. Biochem. J. 1988; 252: 17–22
   PubMed Web of Science ®Google Scholar
• McGrath T., Center M. S. Adriamycin resistance in HL60 cells in the absence of detectable P-glycoprotein. Biochem. Biophys. Res. Commun. 1987; 145: 1171–1176
   PubMed Web of Science ®Google Scholar
• Meger M., Meger-Kossien I., Dietrich M., Tricker A. R., Scherer G., Adlkofer F. Metabolites of 4-(N-methylnitrosamino)-1-(3-pyridyl)-1-butanone in urine of smokers. Eur. J. Cancer Prev. 1996; 5(Suppl 1)121–124
   PubMed Web of Science ®Google Scholar
• Melka M. Oracin-Preclinical Summary Report of the Research Institute for Pharmacy and Biochemistry. Czech Republic, Prague 1993
   Google Scholar
• Michel-Briand Y. Relationship between the structure of a steroid and the inducing effect on 3alpha-hydroxysteroid: NAD oxidoreductase of Pseudomonas testosteroni. Eur. J. Biochem. 1969; 10: 132–139
   PubMedGoogle Scholar
• Michel-Briand Y., Roux J. Role of the composition of the culture medium in the delay of appearance of the 3alpha-hydroxysteroid enzyme: NAD-Oxidoreductase (EC I.I.I.50) of Pseudomonas testoteroni. (Catabolic repression phenomenon). Ann. Inst. Pasteur (Paris) 1969; 116: 448–473
   PubMedGoogle Scholar
• Miko M., Krepelka J., Melka M. Effects of benfluron and its two metabolites on respiratory processes in P388 murine leukemia and Ehrlich ascites cells. Biochem. Pharmacol. 1991; 42(Suppl)S214–216
   PubMed Web of Science ®Google Scholar
• Miko M., Poturnajova M., Soucek R. Cytotoxicity and mode of action of the potential cytostatic drug oracin. Neoplasma 2002; 49: 167–171
   PubMed Web of Science ®Google Scholar
• Mobus E., Jahn M., Schmid R., Jahn D., Maser E. Testosterone-regulated expression of enzymes involved in steroid and aromatic hydrocarbon catabolism in Comamonas testosteroni. J. Bacteriol. 1997; 179: 5951–5955
   PubMed Web of Science ®Google Scholar
• Mobus E., Maser E. Molecular cloning, overexpression, and characterization of steroid-inducible 3alpha-hydroxysteroid dehydrogenase/carbonyl reductase from Comamonas testosteroni. A novel member of the short-chain dehydrogenase/reductase superfamily. J. Biol. Chem. 1998; 273: 30888–30896
   PubMed Web of Science ®Google Scholar
• Monder C., Shackleton C. H. 11Beta-hydroxysteroid dehydrogenase: Fact or fancy?. Steroids 1984; 44: 383–417
   PubMed Web of Science ®Google Scholar
• Monder C., Stewart P. M., Lakshmi V., Valentino R., Burt D., Edwards C. R. Licorice inhibits corticosteroid 11beta-dehydrogenase of rat kidney and liver: In vivo and in vitro studies. Endocrinology 1989; 125: 1046–1053
   PubMed Web of Science ®Google Scholar
• Monder C., White P. C. 11Beta-hydroxysteroid dehydrogenase. Vitam. Horm. 1993; 47: 187–271
   PubMed Web of Science ®Google Scholar
• Monks T. J., Hanzlik R. P., Cohen G. M., Ross D., Graham D. G. Quinone chemistry and toxicity. Toxicol. Appl. Pharmacol. 1992; 112: 2–16
   PubMed Web of Science ®Google Scholar
• Moore C. C., Mellon S. H., Murai J., Siiteri P. K., Miller W. L. Structure and function of the hepatic form of 11beta-hydroxysteroid dehydrogenase in the squirrel monkey, an animal model of glucocorticoid resistance. Endocrinology 1993; 133: 368–375
   PubMed Web of Science ®Google Scholar
• Morton N. M., Holmes M. C., Fievet C., Staels B., Tailleux A., Mullins J. J., Seckl J. R. Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice. J. Biol. Chem. 2001; 276: 41293–41300
   PubMed Web of Science ®Google Scholar
• Nadkarni D. V., Sayre L. M. Structural definition of early lysine and histidine adduction chemistry of 4-hydroxynonenal. Chem. Res. Toxicol. 1995; 8: 284–291
   PubMed Web of Science ®Google Scholar
• Nakajin S., Tamura F., Takase N., Toyoshima S. Carbonyl reductase activity exhibited by pig testicular 20beta-hydroxysteroid dehydrogenase. Biol. Pharm. Bull. 1997; 20: 1215–1218
   PubMed Web of Science ®Google Scholar
• Nakanishi M., Deyashiki Y., Nakayama T., Sato K., Hara A. Cloning and sequence analysis of a cDNA encoding tetrameric carbonyl reductase of pig lung. Biochem. Biophys. Res. Commun. 1993; 194: 1311–1316
   PubMed Web of Science ®Google Scholar
• Nakanishi M., Deyashiki Y., Ohshima K., Hara A. Cloning, expression and tissue distribution of mouse tetrameric carbonyl reductase. Identity with an adipocyte 27-kDa protein. Eur. J. Biochem. 1995; 228: 381–387
   PubMedGoogle Scholar
• Nakayama T., Hara A., Sawada H. Purification and characterization of a novel pyrazole-sensitive carbonyl reductase in guinea pig lung. Arch. Biochem. Biophys. 1982; 217: 564–573
   PubMed Web of Science ®Google Scholar
• Nakayama T., Hara A., Yashiro K., Sawada H. Reductases for carbonyl compounds in human liver. Biochem. Pharmacol. 1985; 34: 107–117
   PubMed Web of Science ®Google Scholar
• Nakayama T., Yashiro K., Inoue Y., Matsuura K., Ichikawa H., Hara A., Sawada H. Characterization of pulmonary carbonyl reductase of mouse and guinea pig. Biochim. Biophys. Acta 1986; 882: 220–227
   PubMed Web of Science ®Google Scholar
• Nakayama T., Matsuura K., Nakagawa M., Hara A., Sawada H. Subcellular distribution and properties of carbonyl reductase in guinea pig lung. Arch. Biochem. Biophys. 1988; 264: 492–501
   PubMed Web of Science ®Google Scholar
• Neupert W., Hartl F. U., Craig E. A., Pfanner N. How do polypeptides cross the mitochondrial membranes?. Cell. 1990; 63: 447–450
   PubMed Web of Science ®Google Scholar
• O'Brien P. J. Molecular mechanisms of quinone cytotoxicity. Chem. Biol. Interact. 1991; 80: 1–41
   PubMed Web of Science ®Google Scholar
• Oh J. W., Lee H. B., Kim C. R., Yum M. K., Koh Y. J., Moon S. J., Kang J. O., Park I. K. Analysis of induced sputum to examine the effects of inhaled corticosteroid on airway inflammation in children with asthma. Ann. Allergy Asthma Immunol. 1999; 82: 491–496
   PubMed Web of Science ®Google Scholar
• Ohara H., Miyabe Y., Deyashiki Y., Matsuura K., Hara A. Reduction of drug ketones by dihydrodiol dehydrogenases, carbonyl reductase and aldehyde reductase of human liver. Biochem. Pharmacol. 1995; 50: 221–227
   PubMed Web of Science ®Google Scholar
• Ohno S., Nakajin S., Shinoda M. 20Beta-hydroxysteroid dehydrogenase of neonatal pig testis: 3Alpha/beta-hydroxysteroid dehydrogenase activities catalyzed by highly purified enzyme. J. Steroid. Biochem. Mol. Biol. 1991; 38: 787–794
   PubMed Web of Science ®Google Scholar
• Olson L. E., Bedja D., Alvey S. J., Cardounel A. J., Gabrielson K. L., Reeves R. H. Protection from doxorubicin-induced cardiac toxicity in mice with a null allele of carbonyl reductase 1. Cancer Res. 2003; 63: 6602–6606
   PubMed Web of Science ®Google Scholar
• Oppermann C. T., Netter K. J., Maser E. Carbonyl reduction by 3alpha-HSD from Comamonas testosteroni–new properties and its relationship to the SCAD family. Adv. Exp. Med. Biol. 1993; 328: 379–390
   PubMedGoogle Scholar
• Oppermann U. C., Belai I., Maser E. Antibiotic resistance and enhanced insecticide catabolism as consequences of steroid induction in the gram-negative bacterium Comamonas testosteroni. J. Steroid. Biochem. Mol. Biol. 1996; 58: 217–223
   PubMed Web of Science ®Google Scholar
• Oppermann U. C., Maser E. Characterization of a 3alpha-hydroxysteroid dehydrogenase/carbonyl reductase from the gram-negative bacterium Comamonas testosteroni. Eur. J. Biochem. 1996; 241: 744–749
   PubMedGoogle Scholar
• Oppermann U. C., Maser E. Molecular and structural aspects of xenobiotic carbonyl metabolizing enzymes. Role of reductases and dehydrogenases in xenobiotic phase I reactions. Toxicology 2000; 144: 71–81
   PubMed Web of Science ®Google Scholar
• Oppermann U. C., Maser E., Mangoura S. A., Netter K. J. Heterogeneity of carbonyl reduction in subcellular fractions and different organs in rodents. Biochem. Pharmacol. 1991; 42(Suppl)S189–195
   PubMed Web of Science ®Google Scholar
• Oppermann U. C., Nagel G., Belai I., Bueld J. E., Genti-Raimondi S., Koolman J., Netter K. J., Maser E. Carbonyl reduction of an anti-insect agent imidazole analogue of metyrapone in soil bacteria, invertebrate and vertebrate species. Chem. Biol. Interact. 1998; 114: 211–224
   PubMed Web of Science ®Google Scholar
• Oppermann U. C., Netter K. J., Maser E. Cloning and primary structure of murine 11 beta-hydroxysteroid dehydrogenase/microsomal carbonyl reductase. Eur. J. Biochem. 1995; 227: 202–208
   PubMedGoogle Scholar
• Oritani H., Deyashiki Y., Nakayama T., Hara A., Sawada H., Matsuura K., Bunai Y., Ohya I. Purification and characterization of pig lung carbonyl reductase. Arch. Biochem. Biophys. 1992; 292: 539–547
   PubMed Web of Science ®Google Scholar
• Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., Tanase T. O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., Nakai K., Yada T., Ohara O., Isogai T., Sugano S. Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat. Genet. 2004; 36: 40–45
   PubMed Web of Science ®Google Scholar
• Ozols R. F., Willson J. K., Weltz M. D., Grotzinger K. R., Myers C. E., Young R. C. Inhibition of human ovarian cancer colony formation by adriamycin and its major metabolites. Cancer Res. 1980; 40: 4109–4112
   PubMed Web of Science ®Google Scholar
• Pal L., Basu G. Novel protein structural motifs containing two-turn and longer 3(10)-helices. Protein Eng. 1999; 12: 811–814
   PubMedGoogle Scholar
• Paolini M., Barillari J., Broccoli M., Pozzetti L., Perocco P., Cantelli-Forti G. Effect of liquorice and glycyrrhizin on rat liver carcinogen metabolizing enzymes. Cancer Lett. 1999; 145: 35–42
   PubMed Web of Science ®Google Scholar
• Park Y. S., Heizmann C. W., Wermuth B., Levine R. A., Steinerstauch P., Guzman J., Blau N. Human carbonyl and aldose reductases: New catalytic functions in tetrahydrobiopterin biosynthesis. Biochem. Biophys. Res. Commun. 1991; 175: 738–744
   PubMed Web of Science ®Google Scholar
• Penning T. M. Molecular endocrinology of hydroxysteroid dehydrogenases. Endocr. Rev. 1997; 18: 281–305
   PubMed Web of Science ®Google Scholar
• Penning T. M. AKR1B10: A new diagnostic marker of non-small cell lung carcinoma in smokers. Clin. Cancer Res. 2005; 11: 1687–1690
   PubMed Web of Science ®Google Scholar
• Penning T. M., Bennett M. J., Smith-Hoog S., Schlegel B. P., Jez J. M., Lewis M. Structure and function of 3 alpha-hydroxysteroid dehydrogenase. Steroids 1997; 62: 101–111
   PubMed Web of Science ®Google Scholar
• Penning T. M., Burczynski M. E., Hung C. F., McCoull K. D., Palackal N. T., Tsuruda L. S. Dihydrodiol dehydrogenases and polycyclic aromatic hydrocarbon activation: Generation of reactive and redox active o-quinones. Chem. Res. Toxicol. 1999; 12: 1–18
   PubMed Web of Science ®Google Scholar
• Penning T. M., Jin Y., Heredia V. V., Lewis M. Structure-function relationships in 3alpha-hydroxysteroid dehydrogenases: A comparison of the rat and human isoforms. J. Steroid. Biochem. Mol. Biol. 2003; 85: 247–255
   PubMed Web of Science ®Google Scholar
• Penning T. M., Mukharji I., Barrows S., Talalay P. Purification and properties of a 3 alpha-hydroxysteroid dehydrogenase of rat liver cytosol and its inhibition by anti-inflammatory drugs. Biochem. J. 1984; 222: 601–611
   PubMed Web of Science ®Google Scholar
• Penning T. M., Pawlowski J. E., Schlegel B. P., Jez J. M., Lin H. K., Hoog S. S., Bennett M. J., Lewis M. Mammalian 3alpha-hydroxysteroid dehydrogenases. Steroids 1996; 61: 508–523
   PubMed Web of Science ®Google Scholar
• Persson B., Kallberg Y., Oppermann U., Jornvall H. Coenzyme-based functional assignments of short-chain dehydrogenases/reductases (SDRs). Chem. Biol. Interact. 2003; 143–144: 271–278
   PubMed Web of Science ®Google Scholar
• Persson B., Krook M., Jornvall H. Characteristics of short-chain alcohol dehydrogenases and related enzymes. Eur. J. Biochem. 1991; 200: 537–543
   PubMedGoogle Scholar
• Peters J., Minuth T., Kula M. R. A novel NADH-dependent carbonyl reductase with an extremely broad substrate range from Candida parapsilosis: Purification and characterization. Enzyme Microb. Technol. 1993; 15: 950–958
   PubMed Web of Science ®Google Scholar
• Pfanner N., Hartl F. U., Neupert W. Import of proteins into mitochondria: a multi-step process. Eur. J. Biochem. 1988; 175: 205–212
   PubMedGoogle Scholar
• Pfanner N., Ostermann J., Rassow J., Hartl F. U., Neupert W. Stress proteins and mitochondrial protein import. Antonie Van Leeuwenhoek. 1990a; 58: 191–193
   PubMed Web of Science ®Google Scholar
• Pfanner N., Rassow J., Guiard B., Sollner T., Hartl F. U., Neupert W. Energy requirements for unfolding and membrane translocation of precursor proteins during import into mitochondria. J. Biol. Chem. 1990b; 265: 16324–16329
   PubMed Web of Science ®Google Scholar
• Pietruszko R., Chen F. F. Aldehyde reductase from rat liver is a 3alpha-hydroxysteroid dehydrogenase. Biochem. Pharmacol. 1976; 25: 2721–2725
   PubMed Web of Science ®Google Scholar
• Propper D., Maser E. Carbonyl reduction of daunorubicin in rabbit liver and heart. Pharmacol. Toxicol. 1997; 80: 240–245
   PubMedGoogle Scholar
• Pu X., Yang K. Guinea pig 11beta-hydroxysteroid dehydrogenase type 1: Primary structure and catalytic properties. Steroids 2000; 65: 148–156
   PubMed Web of Science ®Google Scholar
• Puranen T., Poutanen M., Ghosh D., Vihko P., Vihko R. Characterization of structural and functional properties of human 17beta-hydroxysteroid dehydrogenase type 1 using recombinant enzymes and site-directed mutagenesis. Mol. Endocrinol. 1997; 11: 77–86
   PubMed Web of Science ®Google Scholar
• Ramachandran C., Yuan Z. K., Huang X. L., Krishan A. Doxorubicin resistance in human melanoma cells: MDR-1 and glutathione S-transferase pi gene expression. Biochem. Pharmacol. 1993; 45: 743–751
   PubMed Web of Science ®Google Scholar
• Reidenberg M. M. Environmental inhibition of 11beta-hydroxysteroid dehydrogenase. Toxicology 2000; 144: 107–111
   PubMed Web of Science ®Google Scholar
• Rekka E. A., Soldan M., Belai I., Netter K. J., Maser E. Biotransformation and detoxification of insecticidal metyrapone analogues by carbonyl reduction in the human liver. Xenobiotica 1996; 26: 1221–1229
   PubMed Web of Science ®Google Scholar
• Ris M. M., von Wartburg J. P. Heterogenity of NADPH-dependent aldehyde reductase from human and rat brain. Eur. J. Biochem. 1973; 37(1)69–77
   PubMedGoogle Scholar
• Roberts S. Preparative Biotrransformations. Wiley & Sons, Chichester, NY 1997
   Google Scholar
• Rosemond M. J., Walsh J. S. Human carbonyl reduction pathways and a strategy for their study in vitro. Drug Metab. Rev. 2004; 36: 335–361
   PubMed Web of Science ®Google Scholar
• Ross D., Siegel D., Beall H., Prakash A. S., Mulcahy R. T., Gibson N. W. DT-Diaphorase in activation and detoxification of quinones. Bioreductive activation of mitomycin C. Cancer Metastasis Rev. 1993; 12: 83–101
   PubMed Web of Science ®Google Scholar
• Rossmann M. G., Liljas A., Bränden C. I., Banaszal L. J. Evolutionary and structural relationships among dehydrogenases. The Enzymes. P.D. Boyer, NY 1975
   Google Scholar
• Sawada H., Hara A. The presence of two NADPH-linked aromatic aldehyde-ketone reductases different from aldehyde reductase in rabbit liver. Biochem. Pharmacol. 1979; 28: 1089–1094
   PubMed Web of Science ®Google Scholar
• Sawada H., Hara A., Kato F., Nakayama T. Purification and properties of reductases for aromatic aldehydes and ketones from guinea pig liver. J. Biochem. (Tokyo) 1979; 86: 871–881
   PubMed Web of Science ®Google Scholar
• Sawada H., Hara A., Nakayama T., Kato F. Reductases for aromatic aldehydes and ketones from rabbit liver. Purification and characterization. J. Biochem. (Tokyo) 1980; 87: 1153–1165
   PubMed Web of Science ®Google Scholar
• Sawada H., Hara A., Nakayama T., Nakagawa M., Inoue Y., Hasebe K., Zhang Y. P. Mouse liver dihydrodiol dehydrogenases. Idntity of the predominant and a minor form with 17beta-hydroxysteroid dehydrogenase and aldehyde reductase. Biochem. Pharmacol. 1988; 37: 453–458
   PubMed Web of Science ®Google Scholar
• Sayre L. M., Smith M. A., Perry G. Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr. Med. Chem. 2001; 8: 721–738
   PubMed Web of Science ®Google Scholar
• Schieber A., Frank R. W., Ghisla S. Purification and properties of prostaglandin 9-ketoreductase from pig and human kidney. Identity with human carbonyl reductase. Eur. J. Biochem. 1992; 206: 491–502
   PubMedGoogle Scholar
• Schieber A., Ghisla S. Prostaglandin 9-ketoreductase from pig and human kidney: purification, properties and identity with human carbonyl reductase. Eicosanoids. 5 Suppl. 1992; S37–38
   Google Scholar
• Schott B., Robert J. Comparative activity of anthracycline 13-dihydrometabolites against rat glioblastoma cells in culture. Biochem. Pharmacol. 1989; 38: 4069–4074
   PubMed Web of Science ®Google Scholar
• Schwartz A. G., Yang P., Swanson G. M. Familial risk of lung cancer among nonsmokers and their relatives. Am. J. Epidemiol. 1996; 144: 554–562
   PubMed Web of Science ®Google Scholar
• Sciotti M. A., Nakajin S., Wermuth B., Baker M. E. Mutation of threonine-241 to proline eliminates autocatalytic modification of human carbonyl reductase. Biochem. J. 2000; 350(Pt 1)89–92
   PubMed Web of Science ®Google Scholar
• Sciotti M., Wermuth B. Coenzyme specificity of human monomeric carbonyl reductase: Contribution of Lys-15, Ala-37 and Arg-38. Chem. Biol. Interact. 2001; 130–132: 871–878
   PubMed Web of Science ®Google Scholar
• Seckl J. R. 11Beta-hydroxysteroid dehydrogenase in the brain: A novel regulator of glucocorticoid action?. Front. Neuroendocrinol. 1997; 18: 49–99
   PubMed Web of Science ®Google Scholar
• Sgraja T., Ulschmid J., Becker K., Schneuwly S., Klebe G., Reuter K., Heine A. Structural insights into the neuroprotective-acting carbonyl reductase Sniffer of Drosophila melanogaster. J. Mol. Biol. 2004; 342: 1613–1624
   PubMed Web of Science ®Google Scholar
• Shapiro H. K. Carbonyl-trapping therapeutic strategies. Am. J. Ther. 1998; 5: 323–353
   PubMedGoogle Scholar
• Shikita M., Talalay P. Preparation of highly purified 3 alpha- and 3 beta-hydroxysteroid dehydrogenases from Pseudomonas sp. Anal. Biochem. 1979; 95: 286–292
   PubMed Web of Science ®Google Scholar
• Skalhegg B. A. 3Alpha-hydroxysteroid dehydrogenase from Pseudomonas testosteroni: Kinetic properties with NAD and its thionicotinamide analogue. Eur. J. Biochem. 1975; 50: 603–609
   PubMedGoogle Scholar
• Skalova L., Nobilis M., Szotakova B., Kondrova E., Savlik M., Wsol V., Pichard-Garcia L., Maser E. Carbonyl reduction of the potential cytostatic drugs benfluron and 3,9-dimethoxybenfluron in human in vitro. Biochem. Pharmacol. 2002; 64: 297–305
   PubMed Web of Science ®Google Scholar
• Smolen A., Anderson A. D. Partial purification and characterization of a reduced nicotinamide adenine dinucleotide phosphate-linked aldehyde reductase from heart. Biochem. Pharmacol. 1976; 25: 317–323
   PubMed Web of Science ®Google Scholar
• Soldan M., Nagel G., Losekam M., Ernst M., Maser E. Interindividual variability in the expression and NNK carbonyl reductase activity of 11beta-hydroxysteroid dehydrogenase 1 in human lung. Cancer Lett. 1999; 145: 49–56
   PubMed Web of Science ®Google Scholar
• Soldan M., Netter K., Maser E. Enzymatic detoxification of daunorubicin as supplementary mechanism to multidrug resistance. Exp. Toxic Path. 1996a; 48(Suppl.II)370–376
   Google Scholar
• Soldan M., Netter K. J., Maser E. Induction of daunorubicin carbonyl reducing enzymes by daunorubicin in sensitive and resistant pancreas carcinoma cells. Biochem. Pharmacol. 1996b; 51: 117–123
   PubMed Web of Science ®Google Scholar
• Stewart P. M., Krozowski Z. S., Gupta A., Milford D. V., Howie A. J., Sheppard M. C., Whorwood C. B. Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11 beta-hydroxysteroid dehydrogenase type 2 gene. Lancet. 1996; 347: 88–91
   PubMed Web of Science ®Google Scholar
• Stewart P. M., Murry B. A., Mason J. I. Type 2 11beta-hydroxysteroid dehydrogenase in human fetal tissues. J. Clin. Endocrinol. Metab. 1994; 78: 1529–1532
   PubMed Web of Science ®Google Scholar
• Strausberg R. L., Feingold E. A., Grouse L. H., Derge J. G., Klausner R. D., Collins F. S., Wagner L., Shenmen C. M., Schuler G. D., Altschul S. F., Zeeberg B., Buetow K. H., Schaefer C. F., Bhat N. K., Hopkins R. F., Jordan H., Moore T., Max S. I., Wang J., Hsieh F., Diatchenko L., Marusina K., Farmer A. A., Rubin G. M., Hong L., Stapleton M., Soares M. B., Bonaldo M. F., Casavant T. L., Scheetz T. E., Brownstein M. J., Usdin T. B., Toshiyuki S., Carninci P., Prange C., Raha S. S., Loquellano N. A., Peters G. J., Abramson R. D., Mullahy S. J., Bosak S. A., McEwan P. J., McKernan K. J., Malek J. A., Gunaratne P. H., Richards S., Worley K. C., Hale S., Garcia A. M., Gay L. J., Hulyk S. W., Villalon D. K., Muzny D. M., Sodergren E. J., Lu X., Gibbs R. A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S., Sanchez A., Whiting M., Madan A., Young A. C., Shevchenko Y., Bouffard G. G., Blakesley R. W., Touchman J. W., Green E. D., Dickson M. C., Rodriguez A. C., Grimwood J., Schmutz J., Myers R. M., Butterfield Y. S., Krzywinski M. I., Skalska U., Smailus D. E., Schnerch A., Schein J. E., Jones S. J., Marra M. A. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc. Natl. Acad. Sci. USA 2002; 99: 16899–16903
   PubMed Web of Science ®Google Scholar
• Suzuki K., Ueda S., Sugiyama M., Imamura S. Cloning and expression of a Pseudomonas 3alpha-hydroxysteroid dehydrogenase-encoding gene in Escherichia coli. Gene. 1993; 130: 137–140
   PubMed Web of Science ®Google Scholar
• Sweet F., Samant B. R. Bifunctional enzyme activity at the same active site: Study of 3alpha and 20beta activity by affinity alkylation of 3alpha, 20beta-hydroxysteroid dehydrogenase with 17-(bromoacetoxy)steroids. Biochemistry 1980; 19: 978–986
   PubMed Web of Science ®Google Scholar
• Szotakova B., Wsol V., Treitjnar F., Skalova L., Kvasnickova E. Studies on the metabolism of the potential cytostatic drug oracin. Species differences. Exp. Toxic. Pathol. 1996; 48(Suppl. II)377–388
   Google Scholar
• Tajima K., Hashizaki M., Yamamoto K., Narimatsu S., Mizutani T. Purification and some properties of two enzymes from rat liver cytosol that catalyze carbonyl reduction of 6-tert-butyl-2, 3-epoxy-5-cyclohexene-1,4-dione, a metabolite of 3-tert-butyl-4-hydroxyanisole. Arch. Biochem. Biophys. 1999; 361: 207–214
   PubMed Web of Science ®Google Scholar
• Talalay P., Dobson M. M., Tapley D. F. Oxidative degradation of testosterone by adaptive enzymes. Nature. 1952; 170: 620–621
   PubMed Web of Science ®Google Scholar
• Tamaoka J., Ha D. M., Komagata K. Reclassification of Pseudomonas acidovorans den Dooren de Jong 1926 and Pseudomonas testosteroni Marcus and Talaly 1956 as Comamonas acidovorans comb. nov. and Comamonas testosteroni comb. nov., with an amended decription of genus Comamonas. Int. J. Syst. Bacteriol. 1987; 37: 52–59
   Google Scholar
• Tanaka M., Bateman R., Rauh D., Vaisberg E., Ramachandani S., Zhang C., Hansen K. C., Burlingame A. L., Trautman J. K., Shokat K. M., Adams C. L. An unbiased cell morphology-based screen for new, biologically active small molecules. PLoS Biol. 2005; 3: e128
   PubMed Web of Science ®Google Scholar
• Tanaka M., Ohno S., Adachi S., Nakajin S., Shinoda M., Nagahama Y. Pig testicular 20 beta-hydroxysteroid dehydrogenase exhibits carbonyl reductase-like structure and activity. cDNA cloning of pig testicular 20beta-hydroxysteroid dehydrogenase. J. Biol. Chem. 1992; 267: 13451–13455
   PubMed Web of Science ®Google Scholar
• Tanaka N., Nonaka T., Nakanishi M., Deyashiki Y., Hara A. Crystallization of mouse lung carbonyl reductase complexed with NADPH and analysis of symmetry of its tetrameric molecule. J. Biochem. (Tokyo) 1995; 118: 871–873
   PubMed Web of Science ®Google Scholar
• Tanaka N., Nonaka T., Nakanishi M., Deyashiki Y., Hara A., Mitsui Y. Crystal structure of the ternary complex of mouse lung carbonyl reductase at 1.8 A resolution: The structural origin of coenzyme specificity in the short-chain dehydrogenase/reductase family. Structure 1996a; 4: 33–45
   PubMed Web of Science ®Google Scholar
• Tanaka N., Nonaka T., Tanabe T., Yoshimoto T., Tsuru D., Mitsui Y. Crystal structures of the binary and ternary complexes of 7alpha-hydroxysteroid dehydrogenase from Escherichia coli. Biochemistry 1996b; 35: 7715–7730
   PubMed Web of Science ®Google Scholar
• Terada T., Sugihara Y., Nakamura K., Mizobuchi H., Maeda M. Further characterization of Chinese hamster carbonyl reductases (CHCRs). Chem. Biol. Interact. 2003; 143–144: 373–381
   PubMed Web of Science ®Google Scholar
• Terada T., Sugihara Y., Nakamura K., Sato R., Sakuma S., Fujimoto Y., Fujita T., Inazu N., Maeda M. Characterization of multiple Chinese hamster carbonyl reductases. Chem. Biol. Interact. 2001; 130–132: 847–861
   PubMed Web of Science ®Google Scholar
• Toffoli G., Simone F., Gigante M., Boiocchi M. Comparison of mechanisms responsible for resistance to idarubicin and daunorubicin in multidrug resistant LoVo cell lines. Biochem. Pharmacol. 1994; 48: 1871–1881
   PubMed Web of Science ®Google Scholar
• Tropschug M., Nicholson D. W., Hartl F. U., Kohler H., Pfanner N., Wachter E., Neupert W. Cyclosporin A-binding protein (cyclophilin) of Neurospora crassa. One gene code for both the cytosolic and mitochondrial forms. J. Biol. Chem. 1988; 263: 14433–14440
   PubMed Web of Science ®Google Scholar
• Tsigelny I., Baker M. E. Structures important in mammalian 11beta- and 17beta-hydroxysteroid dehydrogenases. J. Steroid. Biochem. Mol. Biol. 1995a; 55: 589–600
   PubMed Web of Science ®Google Scholar
• Tsigelny I., Baker M. E. Structures stabilizing the dimer interface on human 11beta-hydroxysteroid dehydrogenase types 1 and 2 and human 15-hydroxyprostaglandin dehydrogenase and their homologs. Biochem. Biophys. Res. Commun. 1995b; 217: 859–868
   PubMed Web of Science ®Google Scholar
• Upadhyaya P., Kenney P. M., Hochalter J. B., Wang M., Hecht S. S. Tumorigenicity and metabolism of 4-(methylnitrosamino)-1- (3-pyridyl)-1-butanol enantiomers and metabolites in the A/J mouse. Carcinogenesis. 1999; 20: 1577–1582
   PubMed Web of Science ®Google Scholar
• Usami N., Ishikura S., Abe H., Nagano M., Uebuchi M., Kuniyasu A., Otagiri M., Nakayama H., Imamura Y., Hara A. Cloning, expression and tissue distribution of a tetrameric form of pig carbonyl reductase. Chem. Biol. Interact. 2003; 143–144: 353–361
   PubMed Web of Science ®Google Scholar
• Usami N., Kitahara K., Ishikura S., Nagano M., Sakai S., Hara A. Characterization of a major form of human isatin reductase and the reduced metabolite. Eur. J. Biochem. 2001; 268: 5755–5763
   PubMedGoogle Scholar
• Valentino R., Tommaselli A. P., Savastano S., Stewart P. M., Ghiggi M. R., Galletti F., Mariniello P., Lombardi G., Edwards C. R. Alcohol inhibits 11beta-hydroxysteroid dehydrogenase activity in rat kidney and liver. Horm. Res. 1995; 43: 176–180
   PubMed Web of Science ®Google Scholar
• Varughese K. I., Skinner M. M., Whiteley J. M., Matthews D. A., Xuong N. H. Crystal structure of rat liver dihydropteridine reductase. Proc. Natl. Acad. Sci. USA 1992; 89: 6080–6084
   PubMed Web of Science ®Google Scholar
• Wada M., Kataoka M., Kawabata H., Yasohara Y., Kizaki N., Hasegawa J., Shimizu S. Purification and characterization of NADPH-dependent carbonyl reductase, involved in stereoselective reduction of ethyl 4-chloro-3-oxobutanoate, from Candida magnoliae. Biosci. Biotechnol. Biochem. 1998; 62: 280–285
   PubMed Web of Science ®Google Scholar
• Waksman S. A. The Actinomycetes. Williams and Wilkins Co, Baltimore, MD 1961
   Google Scholar
• Watanabe K., Sugawara C., Ono A., Fukuzumi Y., Itakura S., Yamazaki M., Tashiro H., Osoegawa K., Soeda E., Nomura T. Mapping of a novel human carbonyl reductase, CBR3, and ribosomal pseudogenes to human chromosome 21q22.2. Genomics. 1998; 52: 95–100
   PubMed Web of Science ®Google Scholar
• Wermuth B. Purification and properties of an NADPH-dependent carbonyl reductase from human brain. Relationship to prostaglandin 9-ketoreductase and xenobiotic ketone reductase. J. Biol. Chem. 1981; 256: 1206–1213
   PubMed Web of Science ®Google Scholar
• Wermuth B. Human carbonyl reductases. Prog. Clin. Biol. Res. 1982; 114: 261–274
   PubMedGoogle Scholar
• Wermuth B. Aldo-keto reductases. Prog. Clin. Biol. Res. 1985; 174: 209–230
   PubMedGoogle Scholar
• Wermuth B. Expression of human and rat carbonyl reductase in E. coli. Comparison of the recombinant enzymes. Adv. Exp. Med. Biol. 1995; 372: 203–209
   PubMedGoogle Scholar
• Wermuth B., Bohren K. M., Ernst E. Autocatalytic modification of human carbonyl reductase by 2-oxocarboxylic acids. FEBS Lett. 1993; 335: 151–154
   PubMed Web of Science ®Google Scholar
• Wermuth B., Bohren K. M., Heinemann G., von Wartburg J. P., Gabbay K. H. Human carbonyl reductase. Nucleotide sequence analysis of a cDNA and amino acid sequence of the encoded protein. J. Biol. Chem. 1988; 263: 16185–16188
   PubMed Web of Science ®Google Scholar
• Wermuth B., Burgisser H., Bohren K., von Wartburg J. P. Purification and characterization of human-brain aldose reductase. Eur. J. Biochem. 1982; 127: 279–284
   PubMedGoogle Scholar
• Wermuth B., Mader-Heinemann G., Ernst E. Cloning and expression of carbonyl reductase from rat testis. Eur. J. Biochem. 1995; 228: 473–479
   PubMedGoogle Scholar
• Wermuth B., Platts K. L., Seidel A., Oesch F. Carbonyl reductase provides the enzymatic basis of quinone detoxication in man. Biochem. Pharmacol. 1986; 35: 1277–1282
   PubMed Web of Science ®Google Scholar
• Willems A., de Vos P., de Lay J. The Prokaryotes, a Handbook on the Biology of Bacteria, Ecophysiology, Isolation, Identification an Applications, A. Balows, H.G. Trueper, M. Dworkin. Springer Verlag, Berlin 1992
   Google Scholar
• Wirth H. P., Wermuth B. Immunochemical characterization of aldo-keto reductases from human tissues. FEBS Lett. 1985; 187: 280–282
   PubMed Web of Science ®Google Scholar
• Wirth H., Wermuth B. Immunohistochemical localization of carbonyl reductase in human tissues. J. Histochem. Cytochem. 1992; 40: 1857–1863
   PubMed Web of Science ®Google Scholar
• Wsol V., Kvasnickova E., Szotakova B., Hais I. M. High-performance liquid chromatographic assay for the separation and characterization of metabolites of the potential cytostatic drug oracine. J. Chromatogr. B Biomed. Appl. 1996; 681: 169–175
   PubMed Web of Science ®Google Scholar
• Wsol V., Skalova L., Szotakova B., Trejtnar F., Kvasnickova E. Sex differences in stereospecificity of oracin reductases in rat in vitro and in vivo. Chirality 1999; 11: 505–509
   PubMed Web of Science ®Google Scholar
• Wsol V., Szotakova B., Kvasnickova E., Fell A. F. High-performance liquid chromatography study of stereospecific microsomal enzymes catalysing the reduction of a potential cytostatic drug, oracin. Interspecies comparison. J. Chromatogr. A. 1998; 797: 197–201
   PubMed Web of Science ®Google Scholar
• Wsol V., Szotakova B., Skalova L., Cepkova H., Kvasnickova E. The main metabolic pathway of oracin, a new potential cytostatic drug, in human liver microsomes and cytosol: Stereoselectivity of reoxidation of the principal metabolite 11-dihydrooracin to oracin. Enantiomer. 2000; 5: 263–270
   PubMedGoogle Scholar
• Wsol V., Szotakova B., Skalova L., Maser E. Stereochemical aspects of carbonyl reduction of the original anticancer drug oracin by mouse liver microsomes and purified 11beta-hydroxysteroid dehydrogenase type 1. Chem. Biol. Interact. 2003; 143–144: 459–468
   PubMed Web of Science ®Google Scholar
• Wsol V., Szotakova B., Skalova L., Maser E. The novel anticancer drug oracin: different stereospecificity and cooperativity for carbonyl reduction by purified human liver 11beta-hydroxysteroid dehydrogenase type 1. Toxicology 2004; 197: 253–261
   PubMed Web of Science ®Google Scholar
• Yamano S., Nakamoto N., Toki S. Purification and characterization of rat liver naloxone reductase that is identical to 3alpha-hydroxysteroid dehydrogenase. Xenobiotica 1999; 29: 917–930
   PubMed Web of Science ®Google Scholar
• Yesair D. W., Thayer P. S., McNitt S., Teague K. Comparative uptake, metabolism and retention of anthracyclines by tumors growing in vitro and in vivo. Eur. J. Cancer. 1980; 16: 901–907
   PubMed Web of Science ®Google Scholar
• Yokota H., Yuasa A., Sato R. Topological disposition of UDP-glucuronyltransferase in rat liver microsomes. J. Biochem. (Tokyo) 1992; 112: 192–196
   PubMed Web of Science ®Google Scholar
• Yum D. Y., Lee B. Y., Pan J. G. Identification of the yqhE and yafB genes encoding two 2, 5-diketo-D-gluconate reductases in Escherichia coli. Appl. Environ. Microbiol. 1999a; 65: 3341–3346
   PubMed Web of Science ®Google Scholar
• Yum M. K., Kim N. S., Oh J. W., Kim C. R., Lee J. W., Kim S. K., Noh C. I., Choi J. Y., Yun Y. S. Non-linear cardiac dynamics and morning dip: An unsound circadian rhythm. Clin. Physiol. 1999b; 19: 56–67
   PubMedGoogle Scholar
• Zelinski T., Peters J., Kula M. R. Purification and characterization of a novel carbonyl reductase isolated from Rhodococcus erythropolis. J. Biotechnol. 1994; 33: 283–292
   PubMed Web of Science ®Google Scholar